Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model

Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model

Background: Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder affecting about 1.5% of children, and its prevalence is increasing. Anxiety is one of the most common comorbid signs of ASD. Despite the increasing prevalence, the pathophysiology of ASD is still poorly understood,...

Full description

Bibliographic Details
Main Authors: Kristóf László, Orsolya Kiss, Dávid Vörös, Kitti Mintál, Tamás Ollmann, László Péczely, Anita Kovács, Olga Zagoracz, Erika Kertes, Veronika Kállai, Bettina László, Edina Hormay, Beáta Berta, Attila Tóth, Zoltán Karádi, László Lénárd
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Biomedicines
Subjects:
oxytocin
autism
valproate
amygdala
anxiety
rat
Online Access:https://www.mdpi.com/2227-9059/10/2/405

Internet

https://www.mdpi.com/2227-9059/10/2/405

Similar Items